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training level, highest obtained training level and the num-
ber of earned credits (range b = 0.059, −0.750, p < 0.001). 
Theta remained unchanged over the course of the training, 
while beta activity increased linearly within training ses-
sions (b = 0.004, 95% CI = [0.0013–0.0067], p = 0.005) 
and over the course of the intervention (b = 0.0052, 95% 
CI = [0.0039–0.0065], p < 0.001). In contrast to the group 
analyses, significant individual learning curves were found 
for both theta and beta over the course of the intervention 
in 39 and 53%, respectively. Individual learning curves 
were not significantly correlated with behavioral changes. 
This study shows that children with ADHD can gain con-
trol over EEG states during neurofeedback, although a lack 
of behavioral correlates may indicate insufficient transfer to 
daily functioning, or to confounding reinforcement of elec-
tromyographic activity. Clinical Trials Registration: This 
trial is registered at the US National Institutes of Health 
(ClinicalTrials.gov, ref. no: NCT01363544); https://clini-
caltrials.gov/show/NCT01363544.
Keywords Neurofeedback · Theta/beta-training · ADHD · 
Paediatric · EEG · Learning curves
Introduction
Attention deficit hyperactivity disorder (ADHD) is a neu-
ropsychiatric disorder that is characterized by a persistent 
pattern of inattentive and/or hyperactive and impulsive 
behavior that interferes with normal social, academic or 
occupational functioning [1, 2]. Currently, the most com-
monly applied intervention for ADHD is treatment with 
stimulant medication. Although stimulant medication is 
effective in short-term symptom reduction [3, 4], there is 
limited knowledge on long-term effectiveness and possible 
Abstract Neurofeedback is widely applied as non-phar-
macological intervention aimed at reducing symptoms 
of ADHD, even though efficacy has not been unequivo-
cally established. Neuronal changes during the neuro-
feedback intervention that resemble learning can provide 
crucial evidence for the feasibility and specificity of 
this intervention. A total of 38 children (aged between 
7 and 13 years) with a DSM-IV-TR diagnosis of ADHD, 
completed on average 29 sessions of theta (4–8 Hz)/
beta (13–20 Hz) neurofeedback training. Dependent vari-
ables included training-related measures as well as theta 
and beta power during baseline and training runs for each 
session. Learning effects were analyzed both within and 
between sessions. To further specify findings, individual 
learning curves were explored and correlated with behav-
ioral changes in ADHD symptoms. Over the course of the 
training, there was a linear increase in participants’ mean 
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long-term negative effects [5]. Therefore, parents may be 
reluctant to agree with stimulant treatment for their child 
[6]. This situation urges the need for effective alternatives 
to pharmacological interventions. However, few alternative 
interventions prove efficacious when only probably blinded 
results are considered [7], which might indicate a consider-
able contribution of non-specific effects to the positive out-
comes reported for alternative interventions. Research into 
working mechanisms of alternative interventions may help to 
distinguish effective from non-effective treatment elements, 
which may contribute to improving and developing non-
pharmacological interventions for children with ADHD.
Neurofeedback is considered a promising non-phar-
macological alternative for the treatment of ADHD. The 
most commonly used type of neurofeedback is based on 
electroencephalogram (EEG) activity of the patient and 
is, therefore, also called EEG biofeedback. During neuro-
feedback training, patients receive feedback of their current 
brain activity. Using operant conditioning principles, the 
aim is that patients learn to modify the activation state of 
their brain. Children with ADHD may have atypical EEG 
power spectra, showing increased theta and decreased 
beta activity [8, 9]. On a behavioral level, theta has been 
negatively related to alertness, whereas beta has been posi-
tively related to attention [10–12]. Accordingly, one of 
the most commonly applied neurofeedback protocol aims 
to decrease theta (4–8 Hz) activity and increase beta (13–
20 Hz) activity [12–15]. Behavioral outcomes for theta/beta 
neurofeedback in children with ADHD vary across stud-
ies. Whereas unblinded randomized controlled trials (RCT) 
reveal superiority of neurofeedback over control conditions 
[16, 17], blinded placebo-controlled studies show similar 
improvements in behavior for neurofeedback and sham-
neurofeedback [18–20].
Surprisingly, data on training progress within and 
between neurofeedback sessions are scarcely considered 
in ADHD [21] and the available results are mixed. Uncon-
trolled studies showed that a majority of children with 
ADHD who displayed elevated theta/beta ratios before 
the training were able to decrease theta [22] or theta/beta 
ratio over the course of theta/beta neurofeedback training 
[23]. In contrast, another study showed that children with 
ADHD were not able to decrease theta/beta ratios over 
the training sessions [24]. Only two RCT studies reported 
on training data of theta/beta protocols. The first study of 
Vollebregt, van Dongen-Boomsma, Buitelaar, and Slaats-
Willemse [20] analyzed a small subsample of ten children 
who received different forms of theta/beta neurofeedback. 
Seven out of ten children showed the desired change over 
time in either theta or beta power. However, all ten children 
showed also changes in one frequency band in the oppo-
site of the trained direction. The second study [25] showed 
that adolescents who received theta/sensorimotor rhythm 
neurofeedback (SMR; 12–15 Hz) became better in sup-
pressing theta within training sessions. However, the mean 
value of theta did not decrease over the entire treatment. 
Both studies [20, 25] reported behavioral improvements 
over time, irrespective of whether the children received 
an active form of theta/beta neurofeedback training or not. 
In conclusion, the current literature remains ambiguous to 
what extend theta and beta activity can be trained in chil-
dren with ADHD and whether such training effects under-
lie the behavioral changes observed.
Other important aspects of neurofeedback concern sta-
bility and generalizability of trained frequencies. If chil-
dren with ADHD are able to adapt theta or beta activity, the 
question is whether this leads to sustainable changes that 
also generalize to situations outside neurofeedback train-
ing sessions. Two RCT studies indeed reported a linear 
decrease in theta activity at midline scalp electrodes after 
the training was completed [26, 27]. In contrast, another 
study did not find any differences in theta or beta activity 
for children following individualized theta/beta neurofeed-
back [28]. Alternatively, when it seems that neurofeedback 
results mainly in state changes, it is of clinical importance 
to know whether this temporary state can be generalized to 
daily activities such as school activities. To promote gen-
eralizability to daily life, some neurofeedback training 
programs apply transfer trials. During these trials, patients 
receive feedback on their performance after the trial is 
completed and do not receive feedback during the trial. 
Additionally, transfer cards, with a visual representation of 
the neurofeedback training screen, may be given to patients 
to use in daily life. Transfer cards are supposed to evoke the 
desired decreased theta/beta ratio as a conditioned response 
and may thus be used to improve attention, for example 
during school assignments.
In summary, several studies investigated the behavioral 
and neurocognitive outcomes of theta/beta neurofeedback; 
however, little is known about specific working mecha-
nisms of theta/beta neurofeedback. Therefore, the aim of 
the current study was to explore the effects of theta/beta 
neurofeedback on EEG activity within and between neu-
rofeedback sessions over the course of a 10-week, 30 ses-
sions theta/beta neurofeedback intervention in children 
with ADHD. More specifically, both training parameters 
between sessions (mean and maximum training level), and 
theta and beta power within and between training sessions, 
were tested for learning effects. Beside these group anal-
yses, we identified individual learners as participants that 
were able to significantly change theta or beta power in the 
desired direction. Generalizability was explored by com-
paring transfer and non-transfer trials, and baseline versus 
training EEG. Additionally, we explored whether the ability 
to adapt EEG theta or beta activity was related to ADHD 
symptom reductions.




This study pertains to a subsample of 38 children that 
were randomized to neurofeedback intervention in a mul-
ticenter three-way parallel group study with balanced ran-
domization into the effects of neurofeedback compared to 
optimally titrated methylphenidate and physical activity 
(applied as a semi-active control condition) in children 
with ADHD (Clinical Trials Registration: ClinicalTrials.
gov, Identifier: NCT01363544). Of the 38 children, 7 had 
comorbid disorders including learning disorders (n = 3), 
autism spectrum disorders (ASS; n = 2), learning disorder 
combined with ASS (n = 1), and learning disorder com-
bined with anxiety disorder (n = 1). Group characteristics 
are listed in Table 1. For further details, please see Janssen 
et al. [27].
Neurofeedback intervention
Neurofeedback consisted of three individual training ses-
sions a week, with each session lasting 45 min includ-
ing 20 min of effective training, over a period of 10 to 
12 weeks. The mean number of completed training sessions 
was 29 (M = 28.53, SD = 2.63, range 19–30). Each train-
ing session consisted of 10 runs and started with a 1-min 
baseline theta/beta index measurement. This baseline meas-
urement was used in the following 10 runs of neurofeed-
back. In sum, theta and beta were recorded during these 
runs and children were rewarded with credits related to 
the size of the improvements compared to baseline. See 
Fig. 1 for a schematic representation of the neurofeedback 
intervention.
In more detail, theta/beta training was applied unidirec-
tionally, with the aim to inhibit theta (4–8 Hz) and rein-
force beta (13–20 Hz) activity at Cz. The THERAPRAX® 
EEG Biofeedback system (Neuroconn GmbH, Germany) 
with a DC-amplifier and a sampling rate of 128 Hz was 
used to transmit and analyze the EEG signal. Reference 
and ground electrodes were attached to right and left mas-
toids, respectively. Electro-oculogram (EOG) was obtained 
with two electrodes at external canthi, and two electrodes 
at infra- and supra-orbital sides. Ocular correction was 
applied as described in Schlegelmilch et al. [29]. Subse-
quently, theta/beta index [theta(μV2/Hz) − beta(μV2/Hz)/
theta(μV2/Hz) + beta(μV2/Hz)] was computed with a 
Table 1  Group characteristics
DBDRS disruptive behavior disorders rating scale (raw scores), 
strengths and weaknesses of ADHD symptoms and normal behavior 
scale (SWAN), SD standard deviation
N Mean SD Range
Age 0038 9.87 1.81 7.2 to 13.6
Gender (male/female) 0038 29/9
IQ 0038 100.45 13.34 81 to 134
DBDRS parent
 Inattention 0038 16.63 5.15 8 to 26
 Hyperactivity/impulsivity 0038 14.50 5.99 3 to 25
DBDRS teacher
 Inattention 0038 15.37 5.29 4 to 25
 Hyperactivity/impulsivity 0038 13.79 6.90 3 to 26
SWAN parent
 Inattention 0038 1.44 0.51 0.22 to 2.33
 Hyperactivity/impulsivity 0038 1.30 0.71 −0.89 to 2.33
SWAN teacher
 Inattention 0037 1.37 0.91 −0.67 to 2.89
 Hyperactivity/impulsivity 0037 1.15 0.92 −1.11 to 2.78
Fig. 1  Schematic representation of the neurofeedback intervention. 
Approximately 3 sessions of neurofeedback were provided in a week, 
with 30 sessions taking 10 weeks. Each neurofeedback session started 
with a 1-min theta/beta baseline recording, which was used for the 
remaining of the session. A session consisted of 10 runs of 2 min 
each (20 min effective training). Each run comprised 4 trials of 30 s. 
Children were instructed to decrease theta/beta compared to the base-
line recording during each trial. Children were rewarded with cred-
its related to the size of the improvements compared to baseline. The 
training level increased or decreased based on performance of former 
runs and ranged between 3 and 52%. Training level increased after 
two successive runs with three successful trials each or after one run 
with four successful trials. Training level decreased after two succes-
sive runs with only one successful trial or after one run with no suc-
cessful trials
 Eur Child Adolesc Psychiatry
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short-time-fourier transformed moving average for direct 
feedback during runs.
Each run comprised four 30-s trials. The first run of the 
first session started on a training level with the aim to reduce 
the theta/beta index with 3% compared to baseline. The 
training level increased or decreased based on performance 
of former runs and ranged between 3 and 52%. Training level 
increased after two successive runs with three successful tri-
als each or after one run with four successful trials. Training 
level decreased after two successive runs with only one suc-
cessful trial or after one run with no successful trials. From 
the second session onwards, training level of the first run 
was set at the second lowest level that was achieved in the 
former session. Theta/beta index was represented to the par-
ticipant by simple graphics on a screen. Successful reduction 
of the theta/beta index as averaged over one trial relative to 
the baseline was rewarded with the appearance of a sun and 
granted with credits. The number of earned credits per trial 
depended on the training level, with more credits for higher 
levels to reinforce and motivate children to increase perfor-
mance: 3 and 5% were rewarded with 1 credit; 10, 12, and 
14% were rewarded with 2 credits; 16, 19, and 23% were 
rewarded with 3 credits; 26, 28, and 30% were rewarded 
with 4 credits; 33, 35, and 37% were rewarded with 5 cred-
its; 40, 42, 45, and 47% were rewarded with 6 credits, and 50 
and 52% were rewarded with 7 credits.
Transfer trials without immediate visual feedback were 
included from session 11 (25%) and session 21 (50%) 
onwards. To further transfer learned behaviors, participants 
were instructed to retrieve their neurofeedback experiences 
by watching printed graphics of the training during school 
and homework. Compliance was verified by questioning 
the participants whether they used the transfer cards over 




During the neurofeedback sessions the trainer kept track 
of the training level represented as the percentage decrease 
in theta/beta index as compared to baseline for each run 
separately as well as the total number of earned credits per 
run. Dependent measures included the mean training level 
over runs within a session (%), the best run of each session 
(maximum achieved training level), and the total number of 
obtained credits per session.
EEG
EEG-recordings were analyzed with Brain Vision Analyzer 
v2.0 (Brain Products GmbH, Germany). A high-pass filter 
of 0.5 Hz, 12 dB/octave and a low-pass filter of 30 Hz, 
48 dB/octave were applied. Ocular correction was applied 
as in Gratton, Coles, and Donchin [30]. Data of the train-
ing baselines and runs were segmented in 2-s epochs. 
Automatic raw data inspection was applied with a maxi-
mum allowed voltage step between samples of 50 μV/ms, 
maximum allowed difference of 120 μV in each segment, 
and permitted amplitude range of −100, 100 μV. Before 
and after detected artifacts, 200 ms of data were removed. 
The lowest permitted activity in intervals was 0.5 μV with 
an interval length of 50 ms. Fast Fourier Transformation 
(FFT) with a 20% Hamming window was applied for taper-
ing, and averages over the artifact-free epochs were cal-
culated. Mean power (μV2) was exported to SPSS for the 
trained frequency bands: theta 4–8 Hz, and beta 13–20 Hz. 
EEG baseline was available for 93 and 92% of the training 
data, respectively.
Behavior
Raw scores on the scales Inattention and Hyperactivity/
Impulsivity of the Strengths and Weaknesses of ADHD 
symptoms and Normal behavior scale (SWAN) [31] were 
used to evaluate the relation between behavioral change 
and theta- and beta-slopes within and between sessions (see 
Statistical Analysis).
Procedure
Prior to the start of the study, approval was obtained 
from the national medical ethics committee (Ref. no: NL 
31641.029.10 CCMO). Children were recruited from 15 
child mental health institutions in the West of the Neth-
erlands. Written informed consent was obtained from the 
parents and children aged 11 years and older. Interven-
tions took place between September 2010 and March 2014. 
The duration of the intervention period was approximately 
10 weeks.
Statistical analysis
All analyses were performed using SPSS version 21.0 
(Corp IBM, released 2012). Values of p < 0.05 were con-
sidered statistically significant. Only significant results are 
reported. For all outcome measures data were available for 
at least 92% of the participants.
Linear mixed models were used to test whether chil-
dren with ADHD were able to learn to adapt EEG theta 
and beta activity within and between neurofeedback ses-
sions over the course of a 10-week, 30 sessions theta/beta 
neurofeedback intervention. Dependent variables included 
training outcomes as well as theta and beta power. The lin-
ear model included linear fixed effects for session and run, 
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a random intercept over participants, and a random slope 
for session and run. Exploratory analyses were conducted 
to assess possible differences in the distribution of transfer 
trials and feedback trials over the sessions, which were per-
formed with the addition of the fixed factor percentage of 
transfer trials and the interaction of percentage of transfer 
trials with session. Additionally, to test whether a parabolic 
function would increase the fit of the model in addition to 
linear functions, analyses were performed with the addition 
of quadratic terms for run and session. Finally, because of 
possible effects of comorbid disorders on the theta/beta ratio 
[32, 33], sensitivity analyses were performed with exclusion 
of the children with ADHD and comorbid disorders (n = 7).
To explore individual learning curves in the ability to 
adapt EEG theta or beta activity within and between 30 
neurofeedback sessions, separate mixed models were per-
formed for theta and beta power for each participant. The 
linear model included linear fixed effects for session and 
run. For each participant, the individual slopes over runs 
and sessions were used to determine whether there was a 
significant decrease in theta power and an increase in beta 
power. Learners were defined as participants able to signifi-
cantly change theta or beta power in the desired direction.
To explore whether the individual ability to adapt EEG 
theta or beta activity was related to behavioral changes, 
linear stepwise regression models were performed with 
SWAN difference scores (SWAN scores post-intervention 
minus pre-intervention) as dependent variables. Two sets of 
independent variables were analyzed: (1) theta slopes over 
runs and theta slopes over sessions and (2) beta slopes over 
runs and beta slopes over sessions. SWAN teacher scores 
were missing for one participant.
Results
Training outcomes
Outcome measures for the total group are listed in Table 2. 
Mean training level increased linearly over the training 
sessions, F(1,1040.164) = 34.61, p < 0.001, b = 0.0877, 
95% CI = [0.0585 to 0.1171], and was accompanied 
by a linear increase in the maximum obtained training 
level over the training sessions, F(1,1041.022) = 29.04, 
p < 0.001, b = 0.1150, 95% CI = [0.0731 to 0.1568]. 
Total number of gained credits also increased over ses-
sions, F(1,1042.525) = 58.08, p < 0.001, b = 0.7501, 95% 
CI = [0.5570 to 0.9433].
EEG learning curves
Theta activity
Training baseline theta activity did not change over the 
course of the sessions, F(1, 969.765) = 0.412, p = 0.521, 
b = −0.0006, 95% CI = [−0.0023 to 0.0012]. During 
Table 2  Outcome measures
 Strengths and Weaknesses of ADHD symptoms and Normal behaviour scale (SWAN)
 SD standard deviation
Available data Mean SD Range
N %
Number of sessions followed 38 28.53 2.63 19.00 to 30.00
Training outcomes
 Mean training level per session (%) 1076 99 6.64 5.61 3.00 to 46.20
 Max training level per session (%) 1076 99 9.94 7.42 3.00 to 52.00
 Amount of gained credits per session 1076 99 28.22 32.18 0.00 to 220.00
EEG theta activity
 Mean theta baseline (μV2) 1007 93 1.71 0.40 0.30 to 3.78
 Mean theta training (μV2) 10002 92 1.67 0.46 0.30 to 4.72
EEG beta activity
 Mean beta baseline (μV2) 1007 93 0.67 0.16 0.21 to 1.78
 Mean beta training (μV2) 10002 92 0.75 0.22 0.19 to 2.50
SWAN parent difference scores: pre- to post-intervention
 Inattention 38 100 −0.32 0.66 −2.22 to 0.78
 Hyperactivity/impulsivity 38 100 −0.29 0.68 −1.67 to 1.44
SWAN teacher difference scores: pre- to post-intervention
 Inattention 37 97 −0.11 0.66 −1.44 to 1.89
 Hyperactivity/impulsivity 37 97 −0.03 0.82 −2.33 to 1.78
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the intervention, theta activity did not change over ses-
sions, F(1, 44.687) = 0.322, p = 0.573, b = −0.0020, 
95% CI = [−0.0090 to 0.0050]. Furthermore, theta 
activity did not change over runs within sessions, F(1, 
1040.445) = 1.844, p = 0.175, b = −0.0010, 95% 
CI = [−0.0004 to 0.0023].
Beta activity
Similar to theta, beta activity during training baseline 
did not change over the sessions, F(1, 971.583) = 1.87, 
p = 0.171, b = 0.0007, 95% CI = [−0.0003 to 0.0016]. In 
contrast, during the intervention, beta activity showed a lin-
ear increase over sessions, F(1, 57.461) = 8.60, p = 0.005, 
b = 0.0040 95% CI = [0.0013 to 0.0067]. Additionally, 
beta activity increased linearly over runs within sessions, 
F(1, 1012.625) = 63.51, p < 0.001, b = 0.0052 95% 
CI = [0.0039 to 0.0065]. EEG learning curves are shown 
in Fig. 2.
Exploratory analyses
Analyses showed that the percentage of transfer trials during 
a session did not significantly influence training results in 
theta and beta bands. Furthermore, quadratic terms did not 
further improve the linear mixed models. Sensitivity anal-
yses showed that results remained essentially unchanged 
when analyses were rerun, excluding children with ADHD 
and comorbid disorders (n = 7), indicating that the presence 
of comorbid disorders did not affect the results. Only a near-
significant effect for baseline beta was found, showing a 
slight increase over the sessions with exclusion of comorbid 
disorders, F(1, 796.367) = 3.862, p = 0.050, b = 0.00095, 
95% CI = [0.000001 to 0.001903]. Complete statistical 
details are provided in Supplementary Table 1.
Individual learning curves
Theta activity
Over the course of the intervention, 23 (61%) participants 
showed a negative slope for theta over the sessions of 
which 15 (39%) participants showed a significant negative 
slope and were indicated as theta session learners. How-
ever, 7 (18%) participants showed a significant change over 
the sessions in the opposite of the desired direction with an 
increase in theta. Over the runs within sessions, 14 (37%) 
of the participants presented a negative slope, although only 
4 (11%) of these participants showed a significant negative 
slope and were indicated as theta run learners. Only one 
(3%) participant showed a significant positive theta slope 
over runs.
Beta activity
A total of 28 (74%) participants showed the desired positive 
beta slope over sessions, of which 20 (53%) participants 
showed a significant positive slope and were indicated as 
Fig. 2  EEG learning effects during neurofeedback. These graphs 
show changes in theta and beta power (μV2) during 1-min baseline 
EEG recordings preceding each neurofeedback session, across ses-
sions (1–30) and within sessions (runs 1–10). The bold lines are 
means, and the upper and lower lines are 95% confidence intervals. 
**p < 0.01, ***p < 0.001
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beta session learners. Over the sessions, 3 (8%) participants 
showed a significant negative beta slope. Thirty-one (82%) 
participants were able to increase beta over runs within ses-
sions and 13 (34%) participants were indicated as beta run 
learners (showing a significant positive slope). There were 
no participants that showed a significant negative beta slope 
over runs.
Behavioral change and EEG slopes
No significant associations were found between beta or 
theta individual slopes over sessions or runs and changes 
in SWAN Inattention and Hyperactivity/impulsivity scales 
(post- minus pre-intervention) as reported by parents and 
teachers. Complete statistical details are provided in Sup-
plementary Table 2.
Discussion
Theta/beta neurofeedback is aimed at altering brain activ-
ity using operant conditioning principles with the goal to 
improve behavior and neurocognitive functioning in chil-
dren with ADHD. However, few studies have demonstrated 
that actual learning takes place during neurofeedback treat-
ment in children with ADHD, which is an essential element 
for the effectivity of the intervention. The results of the 
current study provide evidence that children with ADHD 
learned to decrease the theta/beta index over the sessions in 
a linear fashion, concordant with the training goals. More 
detailed analysis of electroencephalogram (EEG) data 
obtained during the intervention seems to ascribe learning 
effects primarily to increasing beta power over and within 
sessions at group level, and at the individual level as well. 
However, for the theta band, analyses of individual EEG 
learning curves showed considerable interindividual varia-
tion, masking potential effects at group level.
An important general aspect of neurofeedback is a cor-
rect translation of learning theory principles to the training 
design [34]. The current study complies with most of the 
suggested relevant learning principles, such as proper tim-
ing of feedback (<250 ms), specificity of the trained EEG 
signal (online EOG correction), shaping (adjusting thresh-
olds and reinforcement magnitude), type of reinforcement 
(simple graphic), and generalization (successful applica-
tion of transfer trials and transfer cards), which are prob-
ably reflected in the successful training results. It should 
be noted that this and other comparable studies still have 
a way to go concerning the specificity of the trained signal. 
First, knowledge about the functional meaning of theta/beta 
ratio should be improved. Second, artifacts, such as electro-
myographic (EMG) activity produced by skeletal muscles, 
may covertly influence theta/beta ratio [35, 36].
In the theta band, we could not demonstrate learning 
effects at the group level; however, more detailed analysis 
of individual learning curves showed considerable hetero-
geneity in training results. While 15 participants signifi-
cantly learned to reduce theta in accordance with the train-
ing goals (39%), 7 children (18%) increased theta and 16 
children (43%) showed no statistically significant training 
effects over sessions. Only the study by Lubar et al. [22] 
found comparable results as in our study, showing 12 sig-
nificant learners (63%) over sessions. We identified only 
few learners in the within-session data, with 4 significant 
learners in line with the training goals (11%), and 1 child 
showing training effects in the opposite direction. One 
other study by Bink et al. [25] demonstrated successful 
suppression of theta within training sessions. An alternative 
explanation for theta decreases in our study may be the fact 
that children show a developmental decrease in theta activ-
ity over time [37, 38], with a drop in theta activity around 
the age of nine years [38]. Since the majority was not able 
to suppress theta within sessions, it is questionable whether 
the negative individual theta slopes over the intervention 
indeed result from the neurofeedback intervention or rather 
originate from developmental changes.
Learning effects were most apparent in the beta fre-
quency band, with linear beta power increases over and 
within 30 sessions of neurofeedback at group level. At 
the individual level, more than half of the children were 
identified as significant beta learners over the sessions, 
and approximately one-third as significant beta learners 
over the runs within the sessions. It is difficult to establish 
whether beta changes represent genuine alterations in brain 
activity or reflect the reinforcement of artifact data, such 
as EMG activity [35, 36]. Although the peak frequency of 
EMG is at relatively high frequencies, the EMG spectrum 
is very broad and may influence adjacent beta frequencies 
more than lower frequency bands such as theta. Despite 
specific instructions during neurofeedback training to pre-
vent excessive muscular tension, it cannot be ruled out that 
some children used more subtle covert muscular tension 
to influence the theta/beta ratio. This explanation is fur-
ther supported by the fact that we could not convincingly 
demonstrate increases in baseline beta, as recorded before 
commencing each neurofeedback training, and the lack of 
chronic beta changes during both rest and task conditions at 
post-measurement [39]. To reduce potential EMG contami-
nation, higher frequencies may be inhibited, such as in the 
Lubar protocol [40], or EMG activity could be separately 
monitored for the major skeletal muscles.
A challenging task is to interpret the various electrophysio-
logical findings of this study. Although we demonstrated learn-
ing effects in theta and beta frequency bands, these were not 
significantly related to symptom improvement in children with 
ADHD, which may be a necessary prerequisite to demonstrate 
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the specificity of the results [21]. Furthermore, the behavio-
ral findings [41] could not confirm the efficacy of theta/beta 
neurofeedback compared to the control group according to 
parent and teacher reports. Surprisingly, at post-treatment, 
children that received theta/beta neurofeedback were charac-
terized by a specific decrease in theta power compared to the 
control group during a resting eyes open condition, but not 
during a task condition [27]. This pattern of results may rep-
resent chronic effects of the intervention, which do not gen-
eralize to a task- and goal-related context, consistent with a 
lack of event-related potential (ERP) effects during the same 
task [42]. It may, therefore, be contradictory that in the cur-
rent study no effects were found for the baseline power spectra 
measurements, which were performed at the start of each neu-
rofeedback training. This might be explained by the fact that 
these measurements were of shorter duration, mostly in the 
afternoon instead of the morning, and in a different context.
A few limitations should be considered when interpret-
ing the findings of the current study. First, although the 
study contained a random sample of children with ADHD 
due to the RCT design, a relative large participant sample 
(n = 38), and large number of EEG data points (30 ses-
sions × 10 trials; approximately 10 h for each participant), 
the design of the study did not allow to compare neuro-
feedback with a placebo-controlled condition. Accordingly, 
this precludes stronger conclusions on the specificity of 
the findings. Future sham-controlled studies could assess 
whether theta and beta changes between and within ses-
sions are due to developmental changes and EMG artefacts 
or not. Second, although training and EEG analyses solely 
involved the vertex location on the scalp, neurofeedback 
may alter a more extended cortical region. Future stud-
ies may add more electrodes to measure widespread EEG 
effects during the intervention, while still confining the 
feedback signal to the vertex. Third, a noticeable qualitative 
observation of within-session beta effects is a steep decline 
in beta power at approximately 3/4 of the session (run 8 out 
of 10) after a linear increase in beta power (run 1 to 7; see 
also Fig. 1). This might indicate that children were not able 
to remain motivated towards the end of the session or that 
they could not sustain the energy demands of the training. 
Future studies may consider these factors, especially con-
sidering potential detrimental effects on acquired learning 
in the first part of the training. Last, cost-effectiveness of 
neurofeedback could be increased with predictive models 
of treatment success. Although learning curves were not 
predictive in the current study, theta power at pre-treatment 
has been found predictive [27]. It would be worthwhile to 
search for additive predictive factors.
Overall, the results of the current study show that learn-
ing took place during theta/beta neurofeedback in chil-
dren with ADHD. However, it remains more difficult to 
interpret these findings, especially since training results 
were not related to behavioral changes. Future studies are 
encouraged to obtain electrophysiological training data 
and to report on the various training components of the 
intervention. This kind of data can play an important role 
in developing more effective neurofeedback interventions 
for ADHD, by isolating trainable components and improv-
ing our understanding of the underlying mechanisms of 
neurofeedback.
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